H Lundbeck A/S
HLUN-A.CO
| Exchange: | CO |
| Currency | Danish krone |
| ISIN: | DK0061804697 |
| Primary Ticker: | HLUN-A.CO |
| Fiscal Year End: | December |
| Sector: | Healthcare |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Gic Sector: | Health Care |
| Gic Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| Gic Industry: | Pharmaceuticals |
| Gic Sub Industry: | Pharmaceuticals |
| Description: | H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally. The company's principal products include Abilify Maintena/Abilify Maintena for schizophrenia and bipolar I disorder in adults; Brintellix/Trintellix to treat depressive disorders; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat MDD and schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat dementia; Onfi for epilepsy; Sabril for the treatment of refractory complex partial seizures and infantile spasms; Xenazine for chorea; Deanxit for depression; Cipramil for depression and anxiety; and Cisordinol to treat psychosis. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership collaboration with Otsuka Pharmaceuticals Co., Ltd.; and collaboration with Alloy Therapeutics, Inc. for the discovery of novel biologics therapies. The company was founded in 1915 and is headquartered in Valby, Denmark. |
| Address: | Ottiliavej 9, Valby, Denmark, 2500 |
| Website: | https://www.lundbeck.com |
| Full Time Employees: | 5800 |
| Updated On: | 2024-08-31 |
Highlights
| Market Capitalization: | 46202093568 |
| Market Capitalization Mln: | 46202.09 |
| EBITDA: | 5310000128 |
| PE Ratio: | 15.78 |
| PEG Ratio: | 9.82 |
| Book Value: | 23.52 |
| Dividend Share: | 0.7 |
| Dividend Yield: | 0.01 |
| Earnings Share: | 2.61 |
| Most Recent Quarter: | 2024-06-30 |
| Profit Margin: | 0.12 |
| Operating Margin TTM: | 0.18 |
| Return On Assets TTM: | 0.05 |
| Return On Equity TTM: | 0.11 |
| Revenue TTM: | 20671000576 |
| Revenue Per Share TTM: | 20.84 |
| Quarterly Revenue Growth YOY: | 0.10 |
| Gross Profit TTM: | 14295000000 |
| Diluted Eps TTM: | 2.61 |
Valuation
| Trailing PE: | 15.78 |
| Forward PE: | 14.06 |
| Price Sales TTM: | 2.23 |
| Price Book MRQ: | 1.76 |
| Enterprise Value: | 44199021337 |
| Enterprise Value Revenue: | 2.13 |
| Enterprise Value Ebitda: | 13.57 |
Shares
| Shares Outstanding: | 198682000 |
| Shares Float: | 304475769 |
| Percent Insiders: | 0.06 |
| Percent Institutions: | 84.21 |
Technicals
| Beta: | 0.17 |
| 52 Week High: | 41.7 |
| 52 Week Low: | 27.1 |
| 50 Day MA: | 36.30 |
| 200 Day MA: | 31.47 |
Splits & Dividends
| Forward Annual Dividend Rate: | 0.7 |
| Forward Annual Dividend Yield: | 0.01 |
| Payout Ratio: | 0.26 |
| Ex Dividend Date: | 2024-03-21 |
Earnings
| Report Date: | 2025-03-20 |
| Date: | 2024-12-31 |
| Before After Market: | Before Market |
| Currency: | DKK |
| Report Date: | 2024-11-13 |
| Date: | 2024-09-30 |
| Before After Market: | Before Market |
| Currency: | DKK |
| Report Date: | 2024-08-06 |
| Date: | 2024-06-30 |
| Before After Market: | Before Market |
| Currency: | DKK |
| Report Date: | 2023-08-15 |
| Date: | 2023-06-30 |
| Before After Market: | Before Market |
| Currency: | DKK |
| Eps Actual: | 0.60 |
| Report Date: | 2023-05-10 |
| Date: | 2023-03-31 |
| Before After Market: | Before Market |
| Currency: | DKK |
| Eps Actual: | 0.88 |
| Report Date: | 2023-02-08 |
| Date: | 2022-12-31 |
| Before After Market: | Before Market |
| Currency: | DKK |
| Eps Actual: | 0.31 |
| Report Date: | 2022-11-09 |
| Date: | 2022-09-30 |
| Before After Market: | Before Market |
| Currency: | DKK |
| Eps Actual: | 0.69 |
| Report Date: | 2022-08-17 |
| Date: | 2022-06-30 |
| Before After Market: | Before Market |
| Currency: | DKK |
| Eps Actual: | 0.50 |
| Date: | 2024-06-30 |
| Eps Actual: | 1.49 |
| Date: | 2022-12-31 |
| Eps Actual: | 1.51 |